Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Traumakine for prevention of multi-organ failure after open surgery for ruptured abdominal aortic aneurysm
2014-000899-25Phase 2Terminated
- Sponsor
- Faron Pharmaceuticals
- Start
- Sep 2016
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in multiple organ dysfunction syndrome (MODS) comparing Traumakine with Placebo (2 arms). Primary endpoint: All-cause mortality at study day 30. Started Sep 2016; status: terminated.
02
Drugs
interferon beta-1a
03
Conditions
multiple organ dysfunction syndrome (MODS)
Beyond the preview
Go deeper on 2014-000899-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000899-25.